Effect of sodium valproate on rat embryo development in vitro

• Autorzy: Biernacki B , Wlodarczyk B. , Minta M.
• Języki publikacji: EN

Abstrakty

EN

Teratogenic effects of the anticonvulsant drug valproic acid (VPA) on the development of rat embryos during early stage of organogenesis were studied using whole embryo culture technique. Embryos with 0-3 somites were exposed in culture to 10, 50 and 100 μg/ml VPA. Growth and development were retarded in embryos exposed to 50 and 100 μg/ml. Drug induced anomalies included open neural tube, irregular somites, and asymmetrically enlarged forebrain. The "no-observed-adverse-effect-level" (NOAEL) was 10 μg/ml VPA.

Słowa kluczowe

EN

teratogenicity; anticonvulsant drug; sodium salt; organogenesis; valproic acid; in vitro; embryo

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2000
• Tom: 44
• Numer: 2
• Opis fizyczny: p.201-206,fig.

Twórcy

autor

Biernacki B

• National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Wlodarczyk B.

autor

Minta M.

Bibliografia

• 1. Biernacki B., Włodarczyk B., Minta M.: Postimplantation Rat Embryo-Culture. Preliminary Study. Acta Poloniae Toxicologica, 1998, 6, 256-269.
• 2. Biernacki B., Włodarczyk B., Minta M.: Mikrometryczna i morfologiczna ocena wczesnego stadium rozwojowego zarodków szczura - zastosowanie w teratologii doświadczalnej i in vitro. Ginekologia Polska, 1998, 69, 919-922.
• 3. Brown N.A., Fabro S.: Qantitation of Rat Embryonic Development In Vitro: A Morphological Scoring System. Teratology, 1981, 24, 65-78.
• 4. Ehlers K., StOurje H., Merker HJ., Nau H.: Valproic acid - induced spina bifida: a mouse model. Naunyn Schemiedebergs Arch. Pharmacol., 1991, Suppl R44.
• 5. Gofflot F., Nassogene M.C., Etizon T., Van Maele-Fabry G., Evrard P., Picard J.J: In vitro neuroteratogenicity of valproic acid and 4-en-VPA. Neurotoxicol. Teratol., 1995, 17, 425-435.
• 6. Guest I., Buttar H.S., Smith S., Varma D.R.: Evaluation of the rat embryo culture system as a predictive test for human teratogens. Can. J. Physiol. Pharmacol., 1994, 72, 57-62.
• 7. Klug S., Lewandowski C., Zappel F., Merker HJ., Nau H., Neubert D.: Effects of valproic acid, some its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo. Arch Toxicol., 1990, 64, 545-553.
• 8. Lindhout D., Omtzigt JG.: Pregnancy and the risk of teratogenicity. Epilepsy, 1992, 33, suppl 4, 41-48.
• 9. Mast T.J., Cukierski M.A., Nau H., Hendrickx A.G.: Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model. Teratology, 1986, 39, 111-119.
• 10. Menegola E., Broccia ML., Nau H., Prati M., Ricolfi R., Giavini E.: Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratog. Carcinog. Mutagen., 1996, 16, 97-108.
• 11. New D.A.T.: Whole-embryo culture and the study of mamalian embryos during organogenesis. Biol. Rev., 1978, 53, 81-122.
• 12. Nurse I., Collins MD., Scott WJ Jr.: Strain difference in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology, 1988, 38, 87-96.
• 13. Seegmiller R.E., Harris C., Luchtel D. L., Juchau M. R.: Morphological difference elicited by two weak acids, retionic and valproic, in rat embryos grown in vitro. Teratology, 1991, 43, 133-150.
• 14. Vorhees C.V., Acuff-Smith K.D., Weisenburger W.P., Minck D.r., Berry J.S ., Setchell K.D., Nau H.: Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats. Teratology, 1991, 43, 583-590.
• 15. Włodarczyk B., Biernacki B., Minta M., Żmudzki J.: Hamster Whole-Embryo Culture as a New in vitro Model for Teratogenicity Testing. Polish Journal of Veterinary Science, 1999, 4, 149-153.